Cameron, D A <br/><br/>
Block sequential adriamycin CMF--optimal non-myeloablative chemotherapy for high risk adjuvant breast cancer?  [electronic resource] 

 -  British journal of cancer  Dec 2002 
 - 1365-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0007-0920 
<br/><br/><label>Standard No.: </label>10.1038/sj.bjc.6600660  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Axilla<br/>Breast Neoplasms--drug therapy<br/>Cyclophosphamide--therapeutic use<br/>Disease-Free Survival<br/>Doxorubicin--therapeutic use<br/>Female<br/>Fluorouracil--therapeutic use<br/>Humans<br/>Lymph Nodes--pathology<br/>Lymphatic Metastasis<br/>Methotrexate--therapeutic use<br/>Middle Aged<br/>Risk Factors<br/>Survival Rate<br/>Treatment Outcome